8-K filing — Orchestra BioMed Holdings, Inc. (OBIO)
Filed: 2026-10-01 AccNo: 0001104659-26-112586 Size: 217 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
BTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target
BTIG analyst Marie Thibault upgrades Orchestra BioMed Hldgs (NASDAQ:OBIO) from Neutral to Buy and announces $10 price target.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Orchestra BioMed Announces Receipt Of $6.1M Milestone Payment From Haemonetics' Acquisition Of Vivasure Medica
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising their price targets.
Crude Oil Surges 6%; Macy’s Shares Fall After Q2 Results
U.S. stocks fell Thursday as the Dow dropped 300+ points; Macy’s slid on weak guidance, while oil rose and producer prices accelerated.